Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	microtubule motor activity	KIF21B DNHD1 KIF1A KIF1B STARD9 KIF1C	1.43e-05	70	150	6	GO:0003777
GeneOntologyMolecularFunction	ATP-dependent activity	KIF21B DNHD1 ABCA1 ATP7A ATRX KIF1A ABCA12 CECR2 KIF1B ORC1 BPTF FBH1 STARD9 ABCG5 KIF1C	6.19e-05	614	150	15	GO:0140657
GeneOntologyMolecularFunction	plus-end-directed microtubule motor activity	KIF1A KIF1B KIF1C	2.62e-04	17	150	3	GO:0008574
GeneOntologyMolecularFunction	cytoskeletal motor activity	KIF21B DNHD1 KIF1A KIF1B STARD9 KIF1C	2.68e-04	118	150	6	GO:0003774
GeneOntologyMolecularFunction	transcription coactivator activity	NCOA2 NCOA3 MAML1 HIPK2 TRRAP MYSM1 NCOA1 MYOCD MAML3	4.86e-04	303	150	9	GO:0003713
GeneOntologyMolecularFunction	ATP hydrolysis activity	KIF21B ABCA1 ATP7A ATRX KIF1A ABCA12 KIF1B ORC1 FBH1 ABCG5 KIF1C	5.13e-04	441	150	11	GO:0016887
GeneOntologyMolecularFunction	type 2 fibroblast growth factor receptor binding	FGF7 FGF10	5.52e-04	5	150	2	GO:0005111
GeneOntologyMolecularFunction	DNA translocase activity	ATRX FBH1	5.52e-04	5	150	2	GO:0015616
GeneOntologyMolecularFunction	nuclear retinoid X receptor binding	NCOA2 NSD1 NCOA1	6.59e-04	23	150	3	GO:0046965
GeneOntologyMolecularFunction	nuclear estrogen receptor binding	NCOA2 NCOA3 NSD1 NCOA1	6.73e-04	53	150	4	GO:0030331
GeneOntologyMolecularFunction	NAD+-protein-cysteine ADP-ribosyltransferase activity	TIPARP PARP12	8.24e-04	6	150	2	GO:0140803
GeneOntologyMolecularFunction	transcription coregulator activity	NCOA2 NCOA3 MAML1 NSD1 HIPK2 TRRAP MYSM1 MAP3K10 NCOA1 MYOCD MAML3 TP53BP1	1.12e-03	562	150	12	GO:0003712
GeneOntologyBiologicalProcess	retrograde neuronal dense core vesicle transport	KIF1A KIF1B KIF1C	7.42e-06	6	150	3	GO:1990049
GeneOntologyBiologicalProcess	anterograde neuronal dense core vesicle transport	KIF1A KIF1B KIF1C	2.06e-05	8	150	3	GO:1990048
GeneOntologyBiologicalProcess	chromatin organization	NCOA3 CHAF1B SATB2 ATRX CECR2 NSD1 HIPK2 BRCC3 TRRAP EMSY MYSM1 BPTF ARID2 CENPI EHMT1 NCOA1 MYOCD RHNO1 TP53BP1	2.81e-05	896	150	19	GO:0006325
GeneOntologyBiologicalProcess	extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration	SRGAP2 SRGAP2C	5.25e-05	2	150	2	GO:0021816
GeneOntologyBiologicalProcess	dense core granule cytoskeletal transport	KIF1A KIF1B KIF1C	7.90e-05	12	150	3	GO:0099519
Domain	DUF1518	NCOA2 NCOA3 NCOA1	4.49e-07	3	144	3	PF07469
Domain	Nuc_rcpt_coact_Ncoa-typ	NCOA2 NCOA3 NCOA1	4.49e-07	3	144	3	IPR014920
Domain	SRC-1	NCOA2 NCOA3 NCOA1	4.49e-07	3	144	3	IPR014935
Domain	Src1_rcpt_coact	NCOA2 NCOA3 NCOA1	4.49e-07	3	144	3	IPR008955
Domain	Nuclear_rcpt_coactivator	NCOA2 NCOA3 NCOA1	4.49e-07	3	144	3	IPR017426
Domain	-	NCOA2 NCOA3 NCOA1	4.49e-07	3	144	3	4.10.630.10
Domain	DUF1518	NCOA2 NCOA3 NCOA1	4.49e-07	3	144	3	IPR010011
Domain	DUF1518	NCOA2 NCOA3 NCOA1	4.49e-07	3	144	3	SM01151
Domain	SRC-1	NCOA2 NCOA3 NCOA1	4.49e-07	3	144	3	PF08832
Domain	Nuc_rec_co-act	NCOA2 NCOA3 NCOA1	4.49e-07	3	144	3	PF08815
Domain	Kinesin_assoc	KIF1A KIF1B KIF1C	8.83e-06	6	144	3	PF16183
Domain	Nuc_rcpt_coact	NCOA2 NCOA3 NCOA1	8.83e-06	6	144	3	IPR009110
Domain	Kinesin_assoc	KIF1A KIF1B KIF1C	8.83e-06	6	144	3	IPR032405
Domain	Kinesin_motor_CS	KIF21B KIF1A KIF1B STARD9 KIF1C	1.52e-05	41	144	5	IPR019821
Domain	-	KIF21B KIF1A KIF1B STARD9 KIF1C	2.17e-05	44	144	5	3.40.850.10
Domain	Kinesin	KIF21B KIF1A KIF1B STARD9 KIF1C	2.17e-05	44	144	5	PF00225
Domain	KISc	KIF21B KIF1A KIF1B STARD9 KIF1C	2.17e-05	44	144	5	SM00129
Domain	KINESIN_MOTOR_1	KIF21B KIF1A KIF1B STARD9 KIF1C	2.17e-05	44	144	5	PS00411
Domain	Kinesin_motor_dom	KIF21B KIF1A KIF1B STARD9 KIF1C	2.17e-05	44	144	5	IPR001752
Domain	KINESIN_MOTOR_2	KIF21B KIF1A KIF1B STARD9 KIF1C	2.17e-05	44	144	5	PS50067
Domain	SMAD_FHA_domain	KIF1A KIF1B IRF9 STARD9 KIF1C	4.93e-05	52	144	5	IPR008984
Domain	DUF4927	NCOA2 NCOA3	5.90e-05	2	144	2	IPR032565
Domain	DUF4927	NCOA2 NCOA3	5.90e-05	2	144	2	PF16279
Domain	FHA	KIF1A KIF1B STARD9 KIF1C	6.01e-05	28	144	4	SM00240
Domain	FHA	KIF1A KIF1B STARD9 KIF1C	9.07e-05	31	144	4	PF00498
Domain	-	KIF1A KIF1B STARD9 KIF1C	1.65e-04	36	144	4	2.60.200.20
Domain	FHA_dom	KIF1A KIF1B STARD9 KIF1C	1.65e-04	36	144	4	IPR000253
Domain	MamL-1	MAML1 MAML3	1.76e-04	3	144	2	SM01275
Domain	Neuroggenic_mastermind-like_N	MAML1 MAML3	1.76e-04	3	144	2	IPR019082
Domain	srGAP2	SRGAP2 SRGAP2C	1.76e-04	3	144	2	IPR030252
Domain	MamL-1	MAML1 MAML3	1.76e-04	3	144	2	PF09596
Domain	Kinesin-like_fam	KIF21B KIF1A KIF1B KIF1C	3.31e-04	43	144	4	IPR027640
Domain	Kinesin-like_KIF1-typ	KIF1A KIF1B	3.51e-04	4	144	2	IPR022140
Domain	KIF1B	KIF1A KIF1B	3.51e-04	4	144	2	PF12423
Domain	NUT	NUTM2A NUTM2B	5.81e-04	5	144	2	IPR024310
Domain	NUT_N	NUTM2A NUTM2B	5.81e-04	5	144	2	IPR024309
Domain	NUT	NUTM2A NUTM2B	5.81e-04	5	144	2	PF12881
Domain	Kinesin-like	KIF1A KIF1B	8.68e-04	6	144	2	IPR022164
Domain	DUF3694	KIF1A KIF1B	8.68e-04	6	144	2	PF12473
Domain	PAS	NCOA2 NCOA3 NCOA1	9.12e-04	25	144	3	PF00989
Domain	PAS_fold	NCOA2 NCOA3 NCOA1	9.12e-04	25	144	3	IPR013767
Domain	-	AKT3 KIF1A NUMBL KIF1B OBSCN ARHGEF12 RTKN MPRIP TLN2 PLCH1	9.20e-04	391	144	10	2.30.29.30
Domain	HMA_dom	ATP7A SRGAP2	1.21e-03	7	144	2	IPR006121
Domain	PH	AKT3 KIF1A KIF1B OBSCN ARHGEF12 RTKN MPRIP PLCH1	1.43e-03	278	144	8	SM00233
Domain	PH_DOMAIN	AKT3 KIF1A KIF1B OBSCN ARHGEF12 RTKN MPRIP PLCH1	1.47e-03	279	144	8	PS50003
Domain	PH_domain	AKT3 KIF1A KIF1B OBSCN ARHGEF12 RTKN MPRIP PLCH1	1.50e-03	280	144	8	IPR001849
Domain	-	RAPGEF4 RFX7 ADAR MYSM1 ORC1 IRF9 ARID2	1.53e-03	218	144	7	1.10.10.10
Domain	FHA_DOMAIN	KIF1A KIF1B KIF1C	1.72e-03	31	144	3	PS50006
Domain	PH_dom-like	AKT3 KIF1A NUMBL KIF1B OBSCN ARHGEF12 RTKN MPRIP TLN2 PLCH1	1.74e-03	426	144	10	IPR011993
Domain	PAS	NCOA2 NCOA3 NCOA1	1.89e-03	32	144	3	SM00091
Domain	RFX_DNA_binding	RFX7 ARID2	2.05e-03	9	144	2	PF02257
Domain	DNA-bd_RFX	RFX7 ARID2	2.05e-03	9	144	2	IPR003150
Domain	RFX_DBD	RFX7 ARID2	2.05e-03	9	144	2	PS51526
Domain	PAS	NCOA2 NCOA3 NCOA1	2.25e-03	34	144	3	PS50112
Domain	PAS	NCOA2 NCOA3 NCOA1	2.25e-03	34	144	3	IPR000014
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	CCP110 NUMBL CEP162 KIF1B BACH1 BRCC3 SRGAP2 ALPK1 SIK3 STIL RFX7 RTKN MPRIP STARD9 MAP3K10 MPHOSPH9 PLCH1 SIPA1L2 KIF1C	9.16e-09	861	153	19	36931259
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	NCOA2 KIF21B NCOA3 ANK3 NUMBL RAPGEF4 NSD1 ARHGEF12 SRGAP2 ZNF318 SIK3 EMSY MPRIP CYFIP1 EHMT1 ELAVL2 TLN2 NEURL4 TP53BP1	5.37e-08	963	153	19	28671696
Pubmed	Absence of the steroid receptor coactivator-3 induces B-cell lymphoma.	NCOA2 NCOA3 NCOA1	8.35e-08	3	153	3	16675958
Pubmed	The function of TIF2/GRIP1 in mouse reproduction is distinct from those of SRC-1 and p/CIP.	NCOA2 NCOA3 NCOA1	8.35e-08	3	153	3	12138202
Pubmed	The transcriptional coregulators TIF2 and SRC-1 regulate energy homeostasis by modulating mitochondrial respiration in skeletal muscles.	NCOA2 NCOA3 NCOA1	8.35e-08	3	153	3	21035760
Pubmed	Distinctive functions of p160 steroid receptor coactivators in proliferation of an estrogen-independent, tamoxifen-resistant breast cancer cell line.	NCOA2 NCOA3 NCOA1	8.35e-08	3	153	3	21059860
Pubmed	Partial hormone resistance in mice with disruption of the steroid receptor coactivator-1 (SRC-1) gene.	NCOA2 NCOA3 NCOA1	8.35e-08	3	153	3	9506940
Pubmed	Steroid receptor coactivators present a unique opportunity for drug development in hormone-dependent cancers.	NCOA2 NCOA3 NCOA1	8.35e-08	3	153	3	28390937
Pubmed	Research resource: loss of the steroid receptor coactivators confers neurobehavioral consequences.	NCOA2 NCOA3 NCOA1	8.35e-08	3	153	3	23927929
Pubmed	Expression and significance of androgen receptor coactivators in urothelial carcinoma of the bladder.	NCOA2 NCOA3 NCOA1	8.35e-08	3	153	3	18845648
Pubmed	In vivo optical trapping indicates kinesin's stall force is reduced by dynein during intracellular transport.	KIF1A KIF1B KIF1C	8.35e-08	3	153	3	23404705
Pubmed	Structure and chromosomal locations of mouse steroid receptor coactivator gene family.	NCOA2 NCOA3 NCOA1	8.35e-08	3	153	3	10501088
Pubmed	The genomic analysis of the impact of steroid receptor coactivators ablation on hepatic metabolism.	NCOA2 NCOA3 NCOA1	8.35e-08	3	153	3	16423883
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	NCOA2 ANK3 NSD1 ZNF318 ANKHD1 TRRAP ADAR EMSY MPRIP BPTF FASN CYFIP1 ARID2 TP53BP1	1.63e-07	549	153	14	38280479
Pubmed	Human transcription factor protein interaction networks.	NCOA2 NCOA3 SATB2 ATXN7L2 ATRX RBM33 MAML1 HIPK2 ZNF318 RFX7 ANKHD1 TRRAP EMSY MPRIP BPTF IRF9 FBN1 ARID2 EHMT1 NCOA1 ELAVL2 TP53BP1	3.31e-07	1429	153	22	35140242
Pubmed	Characterization of a Steroid Receptor Coactivator Small Molecule Stimulator that Overstimulates Cancer Cells and Leads to Cell Stress and Death.	NCOA2 NCOA3 NCOA1	3.33e-07	4	153	3	26267537
Pubmed	Nuclear hormone receptor coregulator GRIP1 suppresses, whereas SRC1A and p/CIP coactivate, by domain-specific binding of MyoD.	NCOA2 NCOA3 NCOA1	3.33e-07	4	153	3	15563453
Pubmed	miR-137 Targets p160 Steroid Receptor Coactivators SRC1, SRC2, and SRC3 and Inhibits Cell Proliferation.	NCOA2 NCOA3 NCOA1	3.33e-07	4	153	3	26066330
Pubmed	P160/SRC/NCoA coactivators form complexes via specific interaction of their PAS-B domain with the CID/AD1 domain.	NCOA2 NCOA3 NCOA1	3.33e-07	4	153	3	18267973
Pubmed	Selective recruitment of p160 coactivators on glucocorticoid-regulated promoters in Schwann cells.	NCOA2 NCOA3 NCOA1	3.33e-07	4	153	3	15331759
Pubmed	Unique roles of p160 coactivators for regulation of breast cancer cell proliferation and estrogen receptor-alpha transcriptional activity.	NCOA2 NCOA3 NCOA1	3.33e-07	4	153	3	19095746
Pubmed	Ablation of steroid receptor coactivator-3 resembles the human CACT metabolic myopathy.	NCOA2 NCOA3 NCOA1	3.33e-07	4	153	3	22560224
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	NCOA2 CCP110 ATRX RBM33 KIF1B MAML1 HIPK2 ZNF318 EMSY MPRIP CYFIP1 ARID2 SIPA1L2 TP53BP1	3.72e-07	588	153	14	38580884
Pubmed	All kinesin superfamily protein, KIF, genes in mouse and human.	KIF21B KIF1A KIF1B STARD9 KIF1C	6.00e-07	37	153	5	11416179
Pubmed	Redundant enhancement of mouse constitutive androstane receptor transactivation by p160 coactivator family members.	NCOA2 NCOA3 NCOA1	8.29e-07	5	153	3	17950690
Pubmed	SIP, a novel ankyrin repeat containing protein, sequesters steroid receptor coactivators in the cytoplasm.	NCOA2 NCOA3 NCOA1	8.29e-07	5	153	3	17476305
Pubmed	Ontogeny of steroid receptor coactivators in the hippocampus and their role in regulating postnatal HPA axis function.	NCOA2 NCOA3 NCOA1	8.29e-07	5	153	3	17854779
Pubmed	Dual role of the arginine methyltransferase CARM1 in the regulation of c-Fos target genes.	NCOA2 NCOA3 NCOA1	8.29e-07	5	153	3	18511550
Pubmed	Ligand-dependent contribution of RXRbeta to cholesterol homeostasis in Sertoli cells.	NCOA2 ABCA1 NCOA1	8.29e-07	5	153	3	14993927
Pubmed	Ligand-independent interactions of p160/steroid receptor coactivators and CREB-binding protein (CBP) with estrogen receptor-alpha: regulation by phosphorylation sites in the A/B region depends on other receptor domains.	NCOA2 NCOA3 NCOA1	8.29e-07	5	153	3	12714702
Pubmed	Regulation of transcription by a protein methyltransferase.	NCOA2 NCOA3 NCOA1	8.29e-07	5	153	3	10381882
Pubmed	Ligands specify coactivator nuclear receptor (NR) box affinity for estrogen receptor subtypes.	NCOA2 NCOA3 NCOA1	8.29e-07	5	153	3	11376110
Pubmed	SRC-1 and GRIP1 coactivate transcription with hepatocyte nuclear factor 4.	NCOA2 NCOA3 NCOA1	8.29e-07	5	153	3	9812974
Pubmed	Transcription activation by the orphan nuclear receptor, chicken ovalbumin upstream promoter-transcription factor I (COUP-TFI). Definition of the domain involved in the glucocorticoid response of the phosphoenolpyruvate carboxykinase gene.	NCOA2 NCOA3 NCOA1	8.29e-07	5	153	3	10652338
Pubmed	SRC-1 null mice exhibit moderate motor dysfunction and delayed development of cerebellar Purkinje cells.	NCOA2 NCOA3 NCOA1	8.29e-07	5	153	3	12514218
Pubmed	Identification of COUP-TFII orphan nuclear receptor as a retinoic acid-activated receptor.	NCOA2 NCOA3 NCOA1	8.29e-07	5	153	3	18798693
Pubmed	Isoform-selective interactions between estrogen receptors and steroid receptor coactivators promoted by estradiol and ErbB-2 signaling in living cells.	NCOA2 NCOA3 NCOA1	8.29e-07	5	153	3	12554772
Pubmed	The opposing transcriptional activities of the two isoforms of the human progesterone receptor are due to differential cofactor binding.	NCOA2 NCOA3 NCOA1	8.29e-07	5	153	3	10757795
Pubmed	Coactivator and corepressor gene expression in rat cerebellum during postnatal development and the effect of altered thyroid status.	NCOA2 NCOA3 NCOA1	8.29e-07	5	153	3	10803578
Pubmed	A novel partial agonist of peroxisome proliferator-activated receptor-gamma (PPARgamma) recruits PPARgamma-coactivator-1alpha, prevents triglyceride accumulation, and potentiates insulin signaling in vitro.	NCOA2 NCOA3 NCOA1	1.65e-06	6	153	3	16373399
Pubmed	Mutual antagonism of estrogen receptors alpha and beta and their preferred interactions with steroid receptor coactivators in human osteoblastic cell lines.	NCOA2 NCOA3 NCOA1	1.65e-06	6	153	3	12630920
Pubmed	Steroid receptor coactivator-3 is required for progesterone receptor trans-activation of target genes in response to gonadotropin-releasing hormone treatment of pituitary cells.	NCOA2 NCOA3 NCOA1	1.65e-06	6	153	3	16728408
Pubmed	Signaling within a coactivator complex: methylation of SRC-3/AIB1 is a molecular switch for complex disassembly.	NCOA2 NCOA3 NCOA1	1.65e-06	6	153	3	16923966
Pubmed	Cellular energy depletion resets whole-body energy by promoting coactivator-mediated dietary fuel absorption.	NCOA2 NCOA3 NCOA1	2.88e-06	7	153	3	21195347
Pubmed	BRCA1-IRIS regulates cyclin D1 expression in breast cancer cells.	NCOA2 NCOA3 NCOA1	2.88e-06	7	153	3	16860316
Pubmed	The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function.	NCOA2 NCOA3 NCOA1	2.88e-06	7	153	3	9192892
Pubmed	Temporal formation of distinct thyroid hormone receptor coactivator complexes in HeLa cells.	NCOA2 NCOA3 NCOA1	2.88e-06	7	153	3	11117530
Pubmed	The AF-1 domain of the orphan nuclear receptor NOR-1 mediates trans-activation, coactivator recruitment, and activation by the purine anti-metabolite 6-mercaptopurine.	NCOA2 NCOA3 NCOA1	2.88e-06	7	153	3	12709428
Pubmed	Mesodermal ALK5 controls lung myofibroblast versus lipofibroblast cell fate.	PRRX1 SFTPB TIPARP FGF7 FGF10	3.39e-06	52	153	5	26984772
Pubmed	Interaction network of human early embryonic transcription factors.	NCOA2 NCOA3 SATB2 MAML1 RFX7 EMSY BPTF ARID2 EHMT1 NCOA1	3.86e-06	351	153	10	38297188
Pubmed	Identification and classification of 16 new kinesin superfamily (KIF) proteins in mouse genome.	KIF1A KIF1B STARD9 KIF1C	4.24e-06	25	153	4	9275178
Pubmed	Synergistic enhancement of nuclear receptor function by p160 coactivators and two coactivators with protein methyltransferase activities.	NCOA2 NCOA3 NCOA1	4.60e-06	8	153	3	11050077
Pubmed	Regulation of SRC-3 (pCIP/ACTR/AIB-1/RAC-3/TRAM-1) Coactivator activity by I kappa B kinase.	NCOA2 NCOA3 NCOA1	4.60e-06	8	153	3	11971985
Pubmed	Targeting of SWI/SNF chromatin remodelling complexes to estrogen-responsive genes.	NCOA2 NCOA3 NCOA1	4.60e-06	8	153	3	12145209
Pubmed	HIV-1 capsids bind and exploit the kinesin-1 adaptor FEZ1 for inward movement to the nucleus.	KIF1A KIF1B KIF1C	4.60e-06	8	153	3	25818806
Pubmed	The activation function-1 domain of Nur77/NR4A1 mediates trans-activation, cell specificity, and coactivator recruitment.	NCOA2 NCOA3 NCOA1	4.60e-06	8	153	3	12082103
Pubmed	Identification of the antibiotic ionomycin as an unexpected peroxisome proliferator-activated receptor γ (PPARγ) ligand with a unique binding mode and effective glucose-lowering activity in a mouse model of diabetes.	NCOA2 NCOA3 NCOA1	4.60e-06	8	153	3	23178929
Pubmed	The Eyes Absent family members EYA4 and EYA1 promote PLK1 activation and successful mitosis through tyrosine dephosphorylation.	NCOA2 NCOA3 RBM33 MAML1 RFX7 NCOA1 MPHOSPH9	5.27e-06	152	153	7	38360978
Pubmed	New nomenclature for chromatin-modifying enzymes.	NCOA2 NCOA3 NSD1 EHMT1 NCOA1	5.37e-06	57	153	5	18022353
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	NCOA2 NCOA3 SATB2 MAML1 SIK3 C1GALT1C1 CYFIP1 ARID2 EHMT1 NCOA1 ELAVL2 MAML3 PCK2	5.41e-06	638	153	13	31182584
Pubmed	NANOG-dependent function of TET1 and TET2 in establishment of pluripotency.	TRRAP EMSY BPTF NANOGP1	5.84e-06	27	153	4	23395962
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	CCP110 NCOA3 TCTN3 ANK3 ATRX NUMBL KIF1B BACH1 MAML1 SRGAP2 RTKN MPRIP CYFIP1 PTPRQ UQCC1 NEURL4 PCK2 TP53BP1 KIF1C	6.01e-06	1321	153	19	27173435
Pubmed	TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation.	NCOA2 NCOA3 ATRX HIPK2 TRRAP ADAR ARID2 NCOA1	6.36e-06	220	153	8	35785414
Pubmed	Structural determinants of the agonist-independent association of human peroxisome proliferator-activated receptors with coactivators.	NCOA2 NCOA3 NCOA1	6.88e-06	9	153	3	15888456
Pubmed	Identification of a novel family of ankyrin repeats containing cofactors for p160 nuclear receptor coactivators.	NCOA2 NCOA3 NCOA1	6.88e-06	9	153	3	15184363
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	NCOA2 NCOA3 SATB2 RBM33 BACH1 MAML1 ZNF318 TRRAP ADAR EMSY BPTF FASN ARID2 EHMT1 NCOA1 TP53BP1 ZNF292	7.91e-06	1103	153	17	34189442
Pubmed	The transcription factor gene Nfib is essential for both lung maturation and brain development.	SFTPB L1CAM FGF7 FGF10	9.03e-06	30	153	4	15632069
Pubmed	Pbx1 activates Fgf10 in the mesenchyme of developing lungs.	SFTPB FGF7 FGF10	9.79e-06	10	153	3	24591256
Pubmed	Transcriptional cofactors exhibit differential preference toward peroxisome proliferator-activated receptors alpha and delta in uterine cells.	NCOA2 NCOA3 NCOA1	9.79e-06	10	153	3	15001550
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	CCP110 STARD8 ALPK1 MYSM1 USF3 ARID2 SPIDR PLCH1 NEURL4 MAML3 KIF1C	1.27e-05	493	153	11	15368895
Pubmed	Nuclear receptor coactivator p160 proteins enhance the HIV-1 long terminal repeat promoter by bridging promoter-bound factors and the Tat-P-TEFb complex.	NCOA2 NCOA3 NCOA1	1.34e-05	11	153	3	11704662
Pubmed	The Hippocampal Response to Acute Corticosterone Elevation Is Altered in a Mouse Model for Angelman Syndrome.	NCOA2 NCOA3 NCOA1	1.34e-05	11	153	3	36613751
Pubmed	Adrenocorticotropic hormone-mediated signaling cascades coordinate a cyclic pattern of steroidogenic factor 1-dependent transcriptional activation.	NCOA2 NCOA3 NCOA1	1.34e-05	11	153	3	16109736
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	NCOA2 NCOA3 SATB2 PRRX1 BACH1 ZNF318 BPTF NANOGP1 ARID2 ZSCAN5C NCOA1 PARP12 ZNF292 CREB3L2	1.46e-05	808	153	14	20412781
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	NCOA2 CHAF1B ANK3 ATRX KIF1A ACO1 KIF1B BACH1 RAPGEF4 BRCC3 SRGAP2 UBASH3A MPRIP FBN1 FBH1 MAP3K10 TLN2 ZNF292	1.53e-05	1285	153	18	35914814
Pubmed	Genomewide screening for fusogenic human endogenous retrovirus envelopes identifies syncytin 2, a gene conserved on primate evolution.	ERVK-9 ERVK-19 ERVFRD-1	1.78e-05	12	153	3	14557543
Pubmed	A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.	ATP7A ANK3 SRGAP2 PLXNB2 MPRIP CYFIP1 NUP155 PLCH1 SIPA1L2 PCK2	1.87e-05	421	153	10	36976175
Pubmed	Quantitative interaction proteomics and genome-wide profiling of epigenetic histone marks and their readers.	CHAF1B ATXN7L2 TRRAP EMSY ORC1 BPTF	1.91e-05	124	153	6	20850016
Pubmed	PRRX1-NCOA1-rearranged fibroblastic tumour: a clinicopathological, immunohistochemical and molecular genetic study of six cases of a potentially under-recognised, distinctive mesenchymal tumour.	PRRX1 NCOA1	1.92e-05	2	153	2	34272753
Pubmed	Cloning of mouse FGF10 and up-regulation of its gene expression during wound healing.	FGF7 FGF10	1.92e-05	2	153	2	9332392
Pubmed	Uterine Tumor Resembling Ovarian Sex Cord Tumor: A Distinct Entity Characterized by Recurrent NCOA2/3 Gene Fusions.	NCOA2 NCOA3	1.92e-05	2	153	2	30273195
Pubmed	SRC-1 and TIF2 control energy balance between white and brown adipose tissues.	NCOA2 NCOA1	1.92e-05	2	153	2	12507421
Pubmed	Steroid receptor coactivator (SRC)-1 and SRC-3 differentially modulate tissue-specific activation functions of the progesterone receptor.	NCOA3 NCOA1	1.92e-05	2	153	2	16141356
Pubmed	The neuron-specific kinesin superfamily protein KIF1A is a unique monomeric motor for anterograde axonal transport of synaptic vesicle precursors.	KIF1A KIF1B	1.92e-05	2	153	2	7539720
Pubmed	SRGAP2 and Its Human-Specific Paralog Co-Regulate the Development of Excitatory and Inhibitory Synapses.	SRGAP2 SRGAP2C	1.92e-05	2	153	2	27373832
Pubmed	Fibroblast growth factors 7 and 10 are involved in ameloblastoma proliferation via the mitogen-activated protein kinase pathway.	FGF7 FGF10	1.92e-05	2	153	2	24002438
Pubmed	Compensatory paracrine mechanisms that define the urothelial response to injury in partial bladder outlet obstruction.	FGF7 FGF10	1.92e-05	2	153	2	17609292
Pubmed	Partially redundant functions of SRC-1 and TIF2 in postnatal survival and male reproduction.	NCOA2 NCOA1	1.92e-05	2	153	2	15070739
Pubmed	Thyroid function in mice with compound heterozygous and homozygous disruptions of SRC-1 and TIF-2 coactivators: evidence for haploinsufficiency.	NCOA2 NCOA1	1.92e-05	2	153	2	11897715
Pubmed	Distinct steady-state nuclear receptor coregulator complexes exist in vivo.	NCOA2 NCOA1	1.92e-05	2	153	2	9751728
Pubmed	Differential interactions of FGFs with heparan sulfate control gradient formation and branching morphogenesis.	FGF7 FGF10	1.92e-05	2	153	2	19755711
Pubmed	Hepatic SRC-1 activity orchestrates transcriptional circuitries of amino acid pathways with potential relevance for human metabolic pathogenesis.	NCOA2 NCOA1	1.92e-05	2	153	2	25148457
Pubmed	Effects of a Levonorgestrel-Releasing Intrauterine System on the Expression of Steroid Receptor Coregulators in Adenomyosis.	NCOA2 NCOA3	1.92e-05	2	153	2	26040939
Pubmed	Fibroblast growth factors 7 and 10 are expressed in the human embryonic pancreatic mesenchyme and promote the proliferation of embryonic pancreatic epithelial cells.	FGF7 FGF10	1.92e-05	2	153	2	15690149
Pubmed	Nonsense mutation of the stereociliar membrane protein gene PTPRQ in human hearing loss DFNB84.	OTOGL PTPRQ	1.92e-05	2	153	2	20472657
Pubmed	No genetic association between ATP binding cassette proteins and Japanese sporadic Alzheimer's disease.	ABCA12 ABCG5	1.92e-05	2	153	2	15980630
Pubmed	Myocardin suppression increases lipid retention and atherosclerosis via downregulation of ABCA1 in vascular smooth muscle cells.	ABCA1 MYOCD	1.92e-05	2	153	2	33035679
Pubmed	Immunohistochemical analysis of keratinocyte growth factor and fibroblast growth factor 10 expression in psoriasis.	FGF7 FGF10	1.92e-05	2	153	2	15679583
Pubmed	Homeostatic levels of SRC-2 and SRC-3 promote early human adipogenesis.	NCOA2 NCOA3	1.92e-05	2	153	2	21220509
Pubmed	The coactivator SRC-1 is an essential coordinator of hepatic glucose production.	NCOA3 NCOA1	1.92e-05	2	153	2	21109193
Interaction	SOX7 interactions	NCOA2 NCOA3 SATB2 CECR2 MAML1 ARID2 NCOA1 ZNF292	1.14e-07	82	142	8	int:SOX7
Interaction	CFAP184 interactions	CCP110 ANK3 SRGAP2 ZNF318 STIL MPHOSPH9 PLCH1 SIPA1L2 BORA	2.25e-06	162	142	9	int:CFAP184
Interaction	PLK1 interactions	DNHD1 SATB2 ATP7A ANK3 KIF1A CEP162 TRRAP TIPARP MPRIP NUP155 MASTL SRPX FAM131B TP53BP1 BORA	3.27e-06	510	142	15	int:PLK1
Interaction	YWHAH interactions	NCOA2 KIF21B CCP110 NCOA3 NUMBL CEP162 KIF1B BRCC3 SRGAP2 SIK3 STIL RFX7 RTKN MPRIP CYFIP1 STARD9 MAP3K10 NCOA1 MPHOSPH9 PLCH1 SIPA1L2 KIF1C	9.28e-06	1102	142	22	int:YWHAH
Interaction	NR5A2 interactions	NCOA2 NCOA3 NSD1 FASN NCOA1	9.89e-06	41	142	5	int:NR5A2
Interaction	HNF4A interactions	NCOA2 NCOA3 SATB2 ATRX TRRAP EMSY BPTF ARID2 EHMT1 NCOA1	2.60e-05	275	142	10	int:HNF4A
Interaction	NUP50 interactions	CHAF1B RBM33 NSD1 ZNF318 MYSM1 TIPARP PPP1R3A NUP155 ARID2 TP53BP1 ZNF292	3.07e-05	341	142	11	int:NUP50
Interaction	WWTR1 interactions	NCOA2 ANK3 ZNF318 ANKHD1 TRRAP ADAR EMSY MPRIP BPTF CYFIP1 ARID2 TP53BP1	4.56e-05	422	142	12	int:WWTR1
Interaction	C6orf141 interactions	SATB2 ZNF318 STIL ANKHD1 PLCH1 SIPA1L2	4.77e-05	92	142	6	int:C6orf141
Interaction	DIO1 interactions	FASN DIO1	4.93e-05	2	142	2	int:DIO1
Interaction	CRYAA interactions	AKT3 SATB2 ZNF318 TRRAP FASN OTOGL FAM131B BORA	6.63e-05	192	142	8	int:CRYAA
Interaction	AR interactions	NCOA2 NCOA3 ATRX KIF1A RBM33 MAML1 NSD1 HIPK2 ZNF318 TYSND1 TRRAP ADAR EMSY MYSM1 TIPARP CYFIP1 ARID2 NCOA1 PARP12	7.01e-05	992	142	19	int:AR
Interaction	TADA1 interactions	ATXN7L2 TRRAP TIPARP FASN TP53BP1	7.01e-05	61	142	5	int:TADA1
Interaction	YWHAB interactions	KIF21B CCP110 CHAF1B NUMBL CEP162 KIF1B SRGAP2 SIK3 RFX7 RTKN TRRAP MPRIP CYFIP1 STARD9 MAP3K10 MPHOSPH9 PLCH1 SIPA1L2 KIF1C	9.36e-05	1014	142	19	int:YWHAB
Interaction	FEV interactions	NCOA2 NCOA3 SATB2 ATRX MAML1 EMSY ARID2 EHMT1	9.78e-05	203	142	8	int:FEV
Cytoband	15q15-q21	TLN2 TP53BP1	6.51e-05	4	152	2	15q15-q21
GeneFamily	Kinesins\|Pleckstrin homology domain containing	KIF21B KIF1A KIF1B STARD9 KIF1C	5.10e-06	46	99	5	622
GeneFamily	Zinc fingers ZZ-type\|Lysine acetyltransferases	NCOA2 NCOA3 NCOA1	1.02e-04	17	99	3	486
GeneFamily	Ataxins\|Trinucleotide repeat containing	NCOA3 NUMBL MAML3	3.36e-04	25	99	3	775
Coexpression	GSE3982_DC_VS_EFF_MEMORY_CD4_TCELL_DN	KIF21B CCP110 AKT3 RNF44 SIK3 STIL TRRAP FASN MPHOSPH9 S1PR4	2.02e-07	197	149	10	M5475
Coexpression	LAKE_ADULT_KIDNEY_C2_PODOCYTES	AKT3 KIF1B BACH1 ARHGEF12 SRGAP2 SIK3 SRGAP2C PTPRQ NCOA1 MAML3	3.98e-07	212	149	10	M39221
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	NCOA2 NCOA3 SATB2 ATRX SRGAP2 SIK3 STIL TRRAP TIPARP BPTF SEC24D NCOA1 MPHOSPH9 SPIDR TP53BP1 ZNF292 CREB3L2	7.94e-06	856	149	17	M4500
Coexpression	GSE21670_TGFB_VS_IL6_TREATED_STAT3_KO_CD4_TCELL_DN	KIF21B CATSPERD L1CAM RAPGEF4 ADAR PARP12 IL27RA ZNF292	1.98e-05	200	149	8	M7432
Coexpression	HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_T_CELL	CCP110 TRABD2A CHAF1B BRCC3 SRGAP2 STIL ORC1 SRGAP2C NUP155 ARID2 MASTL MPHOSPH9 MTFR2 RHNO1 PCK2 MUTYH BORA	2.60e-05	939	149	17	M45768
CoexpressionAtlas	facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4	NCOA2 KIF21B CCP110 AKT3 ATRX KIF1A NUMBL CEP162 KIF1B L1CAM NSD1 HIPK2 SIK3 STIL RTKN EMSY TIPARP ORC1 BPTF SEMA5B HPS1 MASTL EHMT1 ELAVL2 PLCH1 TP53BP1	1.41e-06	1370	143	26	facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4
CoexpressionAtlas	DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_top-relative-expression-ranked_1000	GABRB2 CCP110 AKT3 ANK3 ATRX RBM33 CEP162 CECR2 HIPK2 BRCC3 RFX7 NUP155 NEGR1 FGF10 MPHOSPH9 PLCH1 BORA ZNF292	5.18e-06	779	143	18	gudmap_developingKidney_e15.5_Cap mesenchyme_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_1000	GABRB2 AKT3 ABCA1 PRRX1 ANK3 ATRX KIF1B RAPGEF4 NSD1 TLN2 MYOCD ZNF292	7.83e-06	369	143	12	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1	NCOA2 NCOA3 TCTN3 ATRX RBM33 CEP162 CECR2 HIPK2 ARHGEF12 WDR27 ANKHD1 PLXNB2 EMSY USF3 MPHOSPH9 SIPA1L2 MAML3	2.05e-05	780	143	17	Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1
CoexpressionAtlas	DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#3_top-relative-expression-ranked_200	ATRX BACH1 MYSM1 TIPARP	2.63e-05	26	143	4	gudmap_developingGonad_e18.5_ovary_200_k3
CoexpressionAtlas	DevelopingKidney_e15.5_Endothelial cells_emap-29977_k-means-cluster#3_top-relative-expression-ranked_1000	NCOA3 AKT3 ATRX RAPGEF4 HIPK2 SRGAP2	3.50e-05	91	143	6	DevelopingKidney_e15.5_Endothelial cells_emap-29977_k3_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_1000	GABRB2 NCOA2 AKT3 ABCA1 PRRX1 ANK3 KIF1B HIPK2 SRGAP2 MYOCD	5.18e-05	312	143	10	gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k2
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#5_top-relative-expression-ranked_500	GABRB2 AKT3 ABCA1 PRRX1 ANK3 NSD1 TLN2 MYOCD	5.22e-05	194	143	8	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k5_500
CoexpressionAtlas	facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2	FAM114A1 SATB2 ABCA1 PRRX1 NUMBL UPRT CFP ALPK1 SIK3 GREB1L SEC24D FBN1 SEMA5B NEGR1 HPS1 NCOA1 FGF7 DUSP10 ABCG5 MUTYH CREB3L2	5.98e-05	1208	143	21	facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_MedNas_2500	NCOA2 CCP110 AKT3 ATRX KIF1A CEP162 CECR2 L1CAM HIPK2 STIL EMSY NRARP ORC1 FASN SEMA5B MASTL ELAVL2 MTFR2 PLCH1 ABCG5 TP53BP1 S1PR4 ZNF292	7.11e-05	1414	143	23	facebase_RNAseq_e10.5_Emin_MedNas_2500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_500	GABRB2 AKT3 ABCA1 PRRX1 NPTX2 ANK3 SRD5A2 NSD1 TLN2 MYOCD ABCG5	1.03e-04	408	143	11	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000	GABRB2 AKT3 ABCA1 PRRX1 NPTX2 ANK3 ATRX KIF1B SRD5A2 RAPGEF4 NSD1 ELAVL2 TLN2 MYOCD ABCG5 ZNF292	1.09e-04	806	143	16	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000	AKT3 SATB2 ABCA1 PRRX1 ATRX KIF1A CECR2 KIF1B L1CAM HIPK2 RTKN TIPARP NRARP SEMA5B NCOA1 ELAVL2 PLCH1 ZNF292	1.15e-04	986	143	18	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_1000_k-means-cluster#4	CCP110 KIF1A KIF1B ARHGEF12 MPRIP SEMA5B ELAVL2 TP53BP1	1.46e-04	225	143	8	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_1000_K4
CoexpressionAtlas	DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#1_top-relative-expression-ranked_1000	CCP110 RBM33 CEP162 RFX7 NEGR1 PLCH1 BORA ZNF292	2.34e-04	241	143	8	gudmap_developingKidney_e15.5_Cap mesenchyme_1000_k1
CoexpressionAtlas	facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K4	KIF21B AKT3 FAM114A1 ABCA1 ATRX NUMBL CFP ALPK1 SIK3 GREB1L BPTF SEC24D FBN1 FBH1 NEGR1 PTPRQ FGF7 SRPX CREB3L2	2.60e-04	1148	143	19	facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K4
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_MedNas_2500_K1	NCOA2 CCP110 AKT3 ATRX KIF1A CEP162 HIPK2 STIL EMSY ORC1 FASN SEMA5B MASTL MTFR2 PLCH1 TP53BP1 S1PR4 ZNF292	2.80e-04	1060	143	18	facebase_RNAseq_e10.5_Emin_MedNas_2500_K1
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3	CCP110 ATRX KIF1A NSD1 HIPK2 UPRT BRCC3 STIL EMSY TIPARP ORC1 BPTF FASN CENPI MASTL MTFR2 MUTYH TP53BP1 BORA ZNF292	2.96e-04	1257	143	20	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3
CoexpressionAtlas	DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_500	ATP7A RNLS ATRX BACH1 ZNF318 MYSM1 TIPARP GREB1L SEMA5B ELAVL2	3.00e-04	387	143	10	gudmap_developingGonad_e16.5_ovary_500
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500	CCP110 ATRX KIF1A CECR2 NSD1 HIPK2 UPRT BRCC3 STIL EMSY TIPARP ORC1 BPTF FASN CENPI MASTL ELAVL2 MTFR2 MUTYH TP53BP1 BORA ZNF292	3.04e-04	1459	143	22	facebase_RNAseq_e10.5_Emin_LatNas_2500
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GABRB2 ABCA12 OBSCN MUC5B OTOGL PTPRQ PCDH15 TLN2 MYOCD PLCH1	7.79e-10	184	151	10	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GABRB2 ABCA12 OBSCN MUC5B OTOGL PTPRQ PCDH15 TLN2 MYOCD PLCH1	7.79e-10	184	151	10	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GABRB2 ABCA12 OBSCN MUC5B OTOGL PTPRQ PCDH15 TLN2 MYOCD PLCH1	7.79e-10	184	151	10	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	Bronchial-NucSeq\|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations	NCOA2 AKT3 ANK3 SFTPB SIK3 RFX7 NCOA1 SPIDR MAML3	2.43e-08	196	151	9	ab53c742866945545a92e2e61850d63c80d9a2a6
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PRRX1 MPRIP SEC24D FBN1 NEGR1 FGF7 FGF10 CREB3L2	1.54e-07	175	151	8	910a075ccaf79de22338ecf321fa0a867f3d7d75
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PRRX1 MPRIP SEC24D FBN1 NEGR1 FGF7 FGF10 CREB3L2	1.54e-07	175	151	8	f0c2eb82e17e8aec2cfa5d83169178f409cc1abc
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	AKT3 PRRX1 FBN1 NEGR1 STARD9 FGF7 FGF10 SRPX	4.27e-07	200	151	8	b4ccffdd79526c85e5273d27b668dbddcddba1ee
ToppCell	Tracheal-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	AKT3 PRRX1 FBN1 NEGR1 STARD9 FGF7 FGF10 SRPX	4.27e-07	200	151	8	c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ABCA1 PRRX1 FBN1 NEGR1 STARD9 FGF7 FGF10 SRPX	4.27e-07	200	151	8	0c25d56292b9e5fefa4521b72635449be1ffd6fe
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA12 CECR2 MUC5B PTPRQ KLF18 FGF10 MYOCD	1.27e-06	160	151	7	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA12 CECR2 MUC5B PTPRQ KLF18 FGF10 MYOCD	1.27e-06	160	151	7	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	BAL-Mild-cDC_4\|Mild / Compartment, Disease Groups and Clusters	ATP7A RNF44 TYSND1 EMSY MPRIP STARD9 MTFR2	2.67e-06	179	151	7	68511e87b12b8253de7771e5ccfc5869248b8450
ToppCell	COVID-19-Heart-Fib_+_EC_+_Pericyte\|Heart / Disease (COVID-19 only), tissue and cell type	AKT3 CTSC SEC24D FBN1 NEGR1 SRPX CREB3L2	4.24e-06	192	151	7	60b1312e84f6d6448365a952469c506c00b5fe93
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA1 ATRX KIF1A KIF1B RAPGEF4 NSD1 NCOA1	4.70e-06	195	151	7	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	Parenchymal-NucSeq\|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations	NCOA2 ANK3 SFTPB SIK3 NCOA1 SPIDR MAML3	5.19e-06	198	151	7	1996373bdccc55aac347d349bd22f6aad6d0c668
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	NCOA2 ANK3 SIK3 RFX7 NCOA1 SPIDR MAML3	5.37e-06	199	151	7	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PRRX1 FBN1 NEGR1 STARD9 FGF7 FGF10 SRPX	5.55e-06	200	151	7	3dd022e974fec7013ba18f333da63f58fbf2dd7c
ToppCell	10x3'2.3-week_12-13-Hematopoietic-HSC/MPP_and_pro-LMPP\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	ANK3 WDR27 MROH8 PLCH1 MUTYH TP53BP1	1.79e-05	160	151	6	60fa1c717410aad7e8647703cb416cd7617cac29
ToppCell	PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ATP7A GPR82 TIPARP NRARP MAP3K10 PNPLA3	1.86e-05	161	151	6	82ed45f144a07856fe92d37426c5f92e259a03a9
ToppCell	LV-16._Neuronal\|World / Chamber and Cluster_Paper	AKT3 NPTX2 ANK3 L1CAM FAM135B NEGR1	2.13e-05	165	151	6	6ed52cb756d21addf46c7f6c457458b01339fe04
ToppCell	droplet-Kidney-nan-3m-Epithelial-Epcam____brush_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SATB2 ADAM32 DIO1 PNPLA3 UGT3A2 PLCH1	2.28e-05	167	151	6	40d102e01ccbc7262d00fafd59ca5234909009cb
ToppCell	COVID-19-Heart-Neuronal\|COVID-19 / Disease (COVID-19 only), tissue and cell type	NPTX2 ANK3 L1CAM NEGR1 OTOGL SIPA1L2	2.36e-05	168	151	6	88c2c574f428c2502b5fe099bd73b0758f668ef6
ToppCell	LV-16._Neuronal\|LV / Chamber and Cluster_Paper	AKT3 NPTX2 ANK3 L1CAM FAM135B NEGR1	2.44e-05	169	151	6	a8fc8ab0f0757e939e213efb61c03cfe390bf7d2
ToppCell	facs-Marrow-T-cells-3m-Myeloid-promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATP7A L1CAM CFP SRGAP2 PLXNB2 C1GALT1C1	2.52e-05	170	151	6	a78d9789c3e7c84a36e1bd380192d7aba4a4d443
ToppCell	facs-Marrow-T-cells-3m-Myeloid-monocyte_+_promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATP7A L1CAM CFP SRGAP2 PLXNB2 C1GALT1C1	2.52e-05	170	151	6	ff68600b945b3a5437b14e5411b3db800d0ccbe5
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PRRX1 FASN FBN1 NEGR1 FGF7 CREB3L2	2.61e-05	171	151	6	972fab891135bd755d5526cbc5a963200067b0a6
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PRRX1 FASN FBN1 NEGR1 FGF7 CREB3L2	2.61e-05	171	151	6	2a77ed79c6f2e700e789c80451a70ecb31639719
ToppCell	facs-Marrow-Granulocytes-3m-Myeloid-monocyte_+_promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CTSC BACH1 CFP PLXNB2 C1GALT1C1 DPEP2	2.97e-05	175	151	6	69b59ec58e64644deb7e07f31ef495ef4a6f6276
ToppCell	droplet-Marrow-nan-3m-Lymphocytic-NK_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SATB2 ABCA1 STARD8 ATP7A L1CAM DPEP2	2.97e-05	175	151	6	cf53a15bfb37b6019e7052ffdf594a9ac040900e
ToppCell	facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ANK3 CECR2 L1CAM SRD5A2 FBH1 PNPLA3	2.97e-05	175	151	6	bb898796662b97f7459b7dda7cecf6a9bde8b055
ToppCell	facs-Marrow-Granulocytes-3m-Myeloid-promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CTSC BACH1 CFP PLXNB2 C1GALT1C1 DPEP2	2.97e-05	175	151	6	4f7498b5a0ed52c348a5f94bcd41d830ba7954ea
ToppCell	facs-Brain_Myeloid-Striatum-24m-Myeloid-macrophage\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	L1CAM CFP F2RL2 TRRAP DPEP2 NEURL4	3.16e-05	177	151	6	f6b9d91d46830d0d207b0abd4ee5a4942fd99774
ToppCell	LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANK3 SFTPB CECR2 PLXNB2 SEC24D PLCH1	3.37e-05	179	151	6	fd2cbee532e7b44113410dca82aec7db1a7fb69f
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-24m-Mesenchymal-brain_pericyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NRARP NUP155 MAP3K10 PLCH1 MAML3 PCK2	3.37e-05	179	151	6	f99500c4a590e5152ded5862690f7fa614d64a80
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-24m-Mesenchymal-Pericyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NRARP NUP155 MAP3K10 PLCH1 MAML3 PCK2	3.37e-05	179	151	6	7d61466181ab73088de3ec8a129d7cfa8cac7ecc
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-24m-Mesenchymal\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NRARP NUP155 MAP3K10 PLCH1 MAML3 PCK2	3.37e-05	179	151	6	6c98ce32cb55cf9cee557449e41b23bdb22f5efd
ToppCell	facs-Heart-RV-24m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADAM32 NRARP SEMA5B MYOCD SIPA1L2 MAML3	3.48e-05	180	151	6	a37cc885fe3f6cb9df69d43358064c83c18412e7
ToppCell	facs-Heart-RV-24m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADAM32 NRARP SEMA5B MYOCD SIPA1L2 MAML3	3.48e-05	180	151	6	63a6d532b16b8b15c7c9102148d7297ee3afd641
ToppCell	BAL-Control-cDC_8\|Control / Compartment, Disease Groups and Clusters	NUMBL CEP162 NRARP SEC24D CENPI MAP3K10	3.58e-05	181	151	6	f370161afef2ec827a7b194c06abb9ac1a507cbb
ToppCell	TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-5\|TCGA-Liver / Sample_Type by Project: Shred V9	CHAF1B STIL ORC1 CENPI MASTL MTFR2	3.81e-05	183	151	6	f604a8b62c7088fad8365dbf8d910fc980bd3ba8
ToppCell	5'-GW_trimst-2-LymphNode-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PRRX1 FBN1 SEMA5B FGF7 FGF10 SRPX	3.93e-05	184	151	6	4d4d8f3f44c67d74c57e7af7b7c158f0157b2f49
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	GABRB2 PRRX1 KIF1A FBN1 PCDH15 FGF7	4.05e-05	185	151	6	7dcdc009c5681ee05dd18968f7e85c3403fe34af
ToppCell	COVID-19-Fibroblasts-Adventitial_FB\|COVID-19 / group, cell type (main and fine annotations)	PRRX1 FBN1 NEGR1 FGF7 TLN2 SRPX	4.05e-05	185	151	6	a5aebf2b9b05b550d021272731d68af9a6b1229d
ToppCell	pdx\|World / Sample and Cell Type and Tumor Cluster (all cells)	NCOA3 BPTF TLN2 MPHOSPH9 SPIDR MAML3	4.17e-05	186	151	6	de8e538c8767d41b8a52f5e58ba1affd4e7244c4
ToppCell	pdx-Tumor_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	NCOA3 BPTF TLN2 MPHOSPH9 SPIDR MAML3	4.17e-05	186	151	6	0b88a87158a9ca8de3bf40a4ff1687150707a5f0
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANK3 SFTPB CTSC CECR2 SEC24D PLCH1	4.17e-05	186	151	6	e83718fabb057100835d3357df407f283d23fe16
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	GABRB2 PRRX1 KIF1A FBN1 PCDH15 FGF7	4.30e-05	187	151	6	5258674d0346e5c51a4b965efcdc1790c970845d
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANK3 SFTPB CTSC CECR2 SEC24D PLCH1	4.43e-05	188	151	6	4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f
ToppCell	Control-Fibroblasts-Adventitial_FB\|Control / group, cell type (main and fine annotations)	PRRX1 FBN1 NEGR1 FGF7 TLN2 SRPX	4.43e-05	188	151	6	706a26c372add839d947749f0521a0e1f5c9b0ec
ToppCell	RA-14._Fibroblast_III\|RA / Chamber and Cluster_Paper	CTSC SIK3 TIPARP FBN1 NEGR1 FGF7	4.56e-05	189	151	6	46e9a58aacd79db5a02898a8c7244e1884adcfd1
ToppCell	facs-Skin-Anagen-3m-Epithelial-actively_dividing_stem_cell\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STIL CENPI MASTL MPHOSPH9 MUTYH BORA	4.56e-05	189	151	6	bfa3ed1360991a3e32fad133017c413f8adc1eba
ToppCell	RA-14._Fibroblast_III\|World / Chamber and Cluster_Paper	CTSC SIK3 TIPARP FBN1 NEGR1 FGF7	4.56e-05	189	151	6	b6e12d24d2b0735730bdc625f8318c1c9c2a9b3b
ToppCell	facs-Skin-Anagen-3m-Epithelial-keratinocyte_stem_cell\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STIL CENPI MASTL MPHOSPH9 MUTYH BORA	4.56e-05	189	151	6	96f10c63656e446b4bb712f012e91ae986f8c2d0
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PRRX1 GREB1L FBN1 NEGR1 FGF7 FGF10	4.70e-05	190	151	6	efb757f11c2809e66ddb48a5c84f5433f111cb7c
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PRRX1 GREB1L FBN1 NEGR1 FGF10 SRPX	4.84e-05	191	151	6	2c51850f5c559d665b8a27a12b75af9ed58dffe1
ToppCell	RV-01._Fibroblast_I\|World / Chamber and Cluster_Paper	AKT3 FBN1 NEGR1 STARD9 FGF10 SRPX	4.84e-05	191	151	6	70c067c54084bfb02c29bab085f4defd477194fb
ToppCell	COPD-Myeloid-cDC2\|Myeloid / Disease state, Lineage and Cell class	TCTN3 TRABD2A SRGAP2 MPRIP SRGAP2C MAML3	4.98e-05	192	151	6	984cdc2f1d93e164bc946d63f58dacb629f82eb7
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PRRX1 FBN1 NEGR1 FGF7 TLN2 SRPX	4.98e-05	192	151	6	e0f4e4470a71bfa81d9dcd8594e5f82aafc24f81
ToppCell	nucseq\|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	NCOA2 ABCA1 SIK3 ANKHD1 SPIDR MAML3	5.12e-05	193	151	6	779276e775cb2492e8dd36436295a536084a6415
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PRRX1 GREB1L FBN1 NEGR1 FGF10 SRPX	5.12e-05	193	151	6	09a9ab029f01234459a88e3e994fe90ef4cbb8c6
ToppCell	COVID-19-Fibroblasts-Other_FB\|COVID-19 / group, cell type (main and fine annotations)	PRRX1 FBN1 NEGR1 FGF7 TLN2 FGF10	5.12e-05	193	151	6	e6b75be08e33c1de079fb5c02f0b4468128b369c
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PRRX1 FBN1 NEGR1 FGF7 TLN2 SRPX	5.12e-05	193	151	6	9ab47b360bee1d4f1092c2269e58acebe9584021
ToppCell	LV-14._Fibroblast_III\|LV / Chamber and Cluster_Paper	CTSC TIPARP NEGR1 FGF7 FGF10 CREB3L2	5.27e-05	194	151	6	927c26aea0147f7a4b8fb3f192de4de263f1b978
ToppCell	proximal-3-Endothelial-Vein\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	DNHD1 C2orf69 WDR27 TLN2 SRPX NEURL4	5.43e-05	195	151	6	c81eb541c15b866f9b6ca6a5f1751c5f1243f4fb
ToppCell	proximal-Endothelial-Vein-3\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	DNHD1 C2orf69 WDR27 TLN2 SRPX NEURL4	5.43e-05	195	151	6	df00f94facc5d6107aac83cef3c64fefc7f8e562
ToppCell	COVID-19-Heart-Fib_1\|Heart / Disease (COVID-19 only), tissue and cell type	AKT3 FBN1 NEGR1 FGF7 SRPX CREB3L2	5.43e-05	195	151	6	f423baa36ac7cdc383c033e35a7d17e6bf913323
ToppCell	COVID-19-Fibroblasts-Alveolar_FB\|COVID-19 / group, cell type (main and fine annotations)	PRRX1 FBN1 NEGR1 PCDH15 FGF7 FGF10	5.43e-05	195	151	6	603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7
ToppCell	proximal-Endothelial-Vein\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	DNHD1 C2orf69 WDR27 TLN2 SRPX NEURL4	5.43e-05	195	151	6	0aebdd635a956dd2367883c1cf73d73ce9790635
ToppCell	RV-02._Fibroblast_II\|World / Chamber and Cluster_Paper	AKT3 FBN1 NEGR1 NCOA1 FGF10 SRPX	5.43e-05	195	151	6	ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48
ToppCell	Bronchial_Biopsy-Mesenchymal-Fibroblasts\|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X	PRRX1 F2RL2 FBN1 FGF7 FGF10 SRPX	5.43e-05	195	151	6	5870b2956d50d6550a3174a220a6cc70c5538d70
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA1 ATRX KIF1A KIF1B RAPGEF4 NCOA1	5.43e-05	195	151	6	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	Bronchial_Biopsy-Mesenchymal\|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X	PRRX1 F2RL2 FBN1 FGF7 FGF10 SRPX	5.58e-05	196	151	6	d37d821229dce716a05c2a5865415e10f79032de
ToppCell	COVID-19-lung-Capillary_Aerocytes\|COVID-19 / Disease (COVID-19 only), tissue and cell type	NCOA3 AKT3 RAPGEF4 ARHGEF12 STARD9 SIPA1L2	5.58e-05	196	151	6	49cc0a2b9739abad61dff7292ea0b14d28ff35c4
ToppCell	Children_(3_yrs)-Mesenchymal\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PRRX1 FBN1 NEGR1 PCDH15 FGF7 TLN2	5.58e-05	196	151	6	bc94909f9b2dc08a59eef1914148b69720569c8f
ToppCell	COVID-19-lung-Capillary_Aerocytes\|lung / Disease (COVID-19 only), tissue and cell type	NCOA3 AKT3 RAPGEF4 ARHGEF12 STARD9 SIPA1L2	5.58e-05	196	151	6	4ac4073380d939a73cec7413e9f3f5ef616d2924
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Deep_Layer\|World / Primary Cells by Cluster	GABRB2 AKT3 NPTX2 ANK3 KIF1A NEGR1	5.74e-05	197	151	6	41e823b14697827f657b13adb3afa581bd91a9cb
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	AKT3 PRRX1 FBN1 NEGR1 FGF7 FGF10	5.74e-05	197	151	6	44673c38384453207871d3fd8e8ba9093cc06bc5
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PRRX1 MPRIP FBN1 NEGR1 FGF7 CREB3L2	5.74e-05	197	151	6	9b480f9c799a244bfee64487abd8a1bf07c9a3a2
ToppCell	LPS_only-Epithelial_alveolar-AT_2\|LPS_only / Treatment groups by lineage, cell group, cell type	ANK3 SFTPB CTSC PLXNB2 SEC24D FASN	5.91e-05	198	151	6	d087e738d69ca9853553fde46d4e7a8906439d32
ToppCell	LPS_IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ANK3 SFTPB CTSC CECR2 PLXNB2 SEC24D	5.91e-05	198	151	6	285f729140b1df029c24f6ca1d2438470ac51794
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PRRX1 MPRIP FBN1 NEGR1 FGF7 CREB3L2	5.91e-05	198	151	6	a860246bcea847249a78fd2e86ed8e04371060db
ToppCell	facs-Brain_Non-Myeloid-Striatum-3m-Macroglial-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CCP110 KIF1B HIPK2 KCNK13 RTKN ERMN	5.91e-05	198	151	6	fef9a4c96450078527b94d25e681410e4ea01b13
ToppCell	mild-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	AKT3 ANK3 ATRX BPTF IRF9 ZNF292	6.07e-05	199	151	6	f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCell	3'-GW_trimst-2-LargeIntestine-Mesenchymal\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PRRX1 CTSC FBN1 NEGR1 FGF7 SRPX	6.07e-05	199	151	6	c007cd51577e31553395ceaed70ad447e5854546
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal-6\|World / Primary Cells by Cluster	AKT3 ANK3 ATRX ARHGEF12 BPTF NCOA1	6.07e-05	199	151	6	1b1bccf4293f11048709d15a3c892c0edf3da3d2
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal\|World / Primary Cells by Cluster	AKT3 ANK3 ATRX ARHGEF12 BPTF NCOA1	6.07e-05	199	151	6	4bee94c116c0da5eba951cb4cea7cc9dcdd6e30f
ToppCell	10x3'2.3-week_17-19-Mesenchymal_fibro-stroma\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	PRRX1 ANK3 FBN1 NEGR1 FGF10 SRPX	6.24e-05	200	151	6	747c61d4e0b746278ae1f45ca4cd556c6961c76a
ToppCell	LPS_IL1RA_TNF-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	ANK3 SFTPB CTSC CECR2 SEC24D FASN	6.24e-05	200	151	6	e8db082aa4d0597500e4f16a5c0ea3e62c6c59ae
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_adventitial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PRRX1 FBN1 NEGR1 FGF7 TLN2 SRPX	6.24e-05	200	151	6	ad3fdcef895400f929f2ae12ff9bd85fd46adb3a
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	AKT3 PRRX1 TIPARP FBN1 NEGR1 FGF7	6.24e-05	200	151	6	a4ec0e80f5422b91b85264a9bb74568dd577e285
ToppCell	tumor_Lymph_Node_/_Brain-Fibroblasts\|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass	PRRX1 F2RL2 FBN1 NEGR1 FGF7 SRPX	6.24e-05	200	151	6	4f7e26b27bd51c32420ed8c2f52d070aee542159
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	ATRX RBM33 ADAR BPTF IRF9 ZNF292	6.24e-05	200	151	6	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	Parenchymal-10x3prime_v2-Stromal-Peri/Epineurial_\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	ABCA1 NUMBL ADAM32 EMSY NEGR1 CREB3L2	6.24e-05	200	151	6	5ad3ea1cf1fcd4100966c5517bc7ed0a1af54317
ToppCell	COVID-19-COVID-19_Mild-Lymphocyte-T/NK-CD4+_T_activated\|COVID-19_Mild / Disease, condition lineage and cell class	TRABD2A ANK3 OBSCN UBASH3A ADAR MPRIP	6.24e-05	200	151	6	d9e8a0d047d4403fb7265fde7448e23a7780785c
ToppCell	10x3'2.3-week_17-19-Mesenchymal_fibro\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	PRRX1 ANK3 FBN1 NEGR1 FGF10 SRPX	6.24e-05	200	151	6	de1d193f773f4e2927baa6fc38d29754b015c6e6
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PRRX1 FBN1 NEGR1 FGF7 TLN2 SRPX	6.24e-05	200	151	6	74e74123ea7bf38d337a3a0248a6a51437c6ab42
ToppCell	droplet-Lung-1m-Hematologic-myeloid-intermediate_monocyte-intermediate_monocyte_l14\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	AKT3 SATB2 ALPK1 PLXNB2 EHMT1	8.75e-05	132	151	5	14a512f433315892bf0326419f23d0d5919d01ec
ToppCell	PBMC-Severe-Myeloid-cDC-cDC-cDC_8\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	KCNK13 NRARP NEGR1 TLN2 BORA	1.19e-04	141	151	5	c14f84bc3921cafbce6fa7f7163ecf3cd9cdf073
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Fibroblasts\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CHAF1B SATB2 CENPI PCDH15 FGF7	1.41e-04	146	151	5	86cddd0e7f954547b7ffdccb0329cd5c4b725ac1
ToppCell	Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	ABCA12 MUC5B CENPI PCDH15 MYOCD	1.55e-04	149	151	5	c5eedb54ef2e0f131aa6730612c921bc19479632
Drug	Antigens, Polyomavirus Transforming	NCOA2 NCOA3 CHAF1B ANK3 SRGAP2 ANKHD1 ADAR IRF9 C1GALT1C1 FASN USF3 ARID2 FGF7 MPHOSPH9 SPIDR SIPA1L2 PARP12 ZNF292	2.68e-07	668	145	18	ctd:D000952
Drug	butamben	NCOA2 NCOA3 NCOA1	4.99e-06	6	145	3	ctd:C004605
Disease	Malignant neoplasm of breast	NCOA2 NCOA3 STARD8 OBSCN CFP ZNF318 SIK3 ADAR EMSY PPP1R3A FASN SEMA5B OTOGL EHMT1 NCOA1 UQCC1 FGF10 TP53BP1	3.91e-06	1074	141	18	C0006142
Disease	total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality, cancer	ANKRD31 ABCA12 SIK3 SEMA5B MAML3	2.04e-05	69	141	5	EFO_0000275, EFO_0000400, EFO_0000712, EFO_0001645, EFO_0003144, EFO_0004340, EFO_0004348, EFO_0004352, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928, MONDO_0004992
Disease	nervous system disease (implicated_via_orthology)	KIF1A KIF1B KIF1C	2.28e-05	12	141	3	DOID:863 (implicated_via_orthology)
Disease	prostate cancer (is_marker_for)	NCOA2 NCOA3 CHAF1B SRD5A2 NCOA1 FGF7	1.08e-04	156	141	6	DOID:10283 (is_marker_for)
Disease	phospholipids:total lipids ratio	ANKRD31 ABCA1 SIK3 BPTF DPEP2 PNPLA3 TP53BP1	1.15e-04	227	141	7	EFO_0020946
Disease	Benign Prostatic Hyperplasia	SRD5A2 FGF7	1.35e-04	4	141	2	C1704272
Disease	Prostatic Hypertrophy	SRD5A2 FGF7	1.35e-04	4	141	2	C1739363
Disease	Prostatic Adenoma	SRD5A2 FGF7	1.35e-04	4	141	2	C0520477
Disease	Benign prostatic hypertrophy	SRD5A2 FGF7	1.35e-04	4	141	2	C0005001
Disease	Prostatic Hyperplasia	SRD5A2 FGF7	1.35e-04	4	141	2	C2937421
Disease	synucleinopathy (biomarker_via_orthology)	KIF1A KIF1B	1.35e-04	4	141	2	DOID:0050890 (biomarker_via_orthology)
Disease	triglycerides in LDL measurement	ABCA1 SIK3 BPTF TP53BP1	1.51e-04	56	141	4	EFO_0022320
Disease	lung adenocarcinoma	NUMBL SFTPB RFX7 BPTF NCOA1 FGF7	1.96e-04	174	141	6	EFO_0000571
Disease	viral infectious disease (implicated_via_orthology)	PTPRQ EHMT1	2.25e-04	5	141	2	DOID:934 (implicated_via_orthology)
Disease	Endometrial Stromal Sarcoma	NUTM2A NUTM2B	2.25e-04	5	141	2	C0206630
Disease	Aortic Rupture	ATP7A FBN1	2.25e-04	5	141	2	C0003496
Disease	Aortic Aneurysm, Ruptured	ATP7A FBN1	2.25e-04	5	141	2	C0741160
Disease	triglycerides in medium LDL measurement	ABCA1 SIK3 BPTF TP53BP1	2.25e-04	62	141	4	EFO_0022322
Disease	triglycerides to total lipids in medium VLDL percentage	ANKRD31 SIK3 ABCG5 TP53BP1	2.39e-04	63	141	4	EFO_0022335
Disease	cholesterol to total lipids in medium VLDL percentage	ANKRD31 SIK3 ABCG5 TP53BP1	2.39e-04	63	141	4	EFO_0022239
Disease	very low density lipoprotein cholesterol measurement	ANKRD31 ABCA1 SIK3 BPTF PNPLA3 ABCG5 TP53BP1	2.64e-04	260	141	7	EFO_0008317
Disease	triglycerides in small LDL measurement	ABCA1 SIK3 BPTF TP53BP1	2.70e-04	65	141	4	EFO_0022323
Disease	phospholipids:total lipids ratio, intermediate density lipoprotein measurement	ABCA1 SIK3 PNPLA3 TP53BP1	3.03e-04	67	141	4	EFO_0008595, EFO_0020946
Disease	Clear cell sarcoma of kidney	NUTM2E NUTM2B	3.36e-04	6	141	2	C0334488
Disease	Prostate cancer, familial	RNLS SRD5A2 RFX7 EMSY	3.39e-04	69	141	4	C2931456
Disease	post-traumatic stress disorder	GABRB2 AKT3 CTSC BPTF CYFIP1 SIPA1L2	4.35e-04	202	141	6	EFO_0001358
Disease	obesity (biomarker_via_orthology)	ABCA1 SFTPB CTSC PNPLA3 ABCG5	7.20e-04	147	141	5	DOID:9970 (biomarker_via_orthology)
Disease	Mammary Carcinoma, Human	NCOA2 NCOA3 STARD8 ADAR EMSY FASN NCOA1 FGF10 TP53BP1	9.82e-04	525	141	9	C4704874
Disease	Mammary Neoplasms, Human	NCOA2 NCOA3 STARD8 ADAR EMSY FASN NCOA1 FGF10 TP53BP1	9.82e-04	525	141	9	C1257931
Disease	neuroblastoma (is_implicated_in)	KIF1B NSD1	9.95e-04	10	141	2	DOID:769 (is_implicated_in)
Disease	Mammary Neoplasms	NCOA2 NCOA3 STARD8 ADAR EMSY FASN NCOA1 FGF10 TP53BP1	1.01e-03	527	141	9	C1458155
Disease	Cleft palate, isolated	SATB2 FGF7 FGF10	1.07e-03	42	141	3	C1837218
Disease	triglycerides in large LDL measurement	ABCA1 SIK3 TP53BP1	1.15e-03	43	141	3	EFO_0022319
Disease	Breast Carcinoma	NCOA2 NCOA3 STARD8 ADAR EMSY FASN NCOA1 FGF10 TP53BP1	1.16e-03	538	141	9	C0678222
Disease	Nephrosclerosis	HIPK2 ALPK1	1.21e-03	11	141	2	C0027719
Disease	glioblastoma (is_marker_for)	CHAF1B ATRX L1CAM	1.23e-03	44	141	3	DOID:3068 (is_marker_for)
Disease	saturated fatty acids measurement	ABCA1 SIK3 TP53BP1	1.31e-03	45	141	3	EFO_0022304
Disease	ADHD symptom measurement	ARHGEF12 PCK2	1.45e-03	12	141	2	EFO_0007860
Disease	BMI-adjusted waist-hip ratio, sex interaction measurement, age at assessment	ABCA1 NSD1 RFX7 UQCC1	1.64e-03	105	141	4	EFO_0007788, EFO_0008007, EFO_0008343
Disease	phospholipids in very small VLDL measurement	SIK3 ABCG5 TP53BP1	1.88e-03	51	141	3	EFO_0022300
Disease	cortical surface area measurement	NCOA2 AKT3 SATB2 RNLS ANK3 CEP162 KIF1B HIPK2 ARHGEF12 PLXNB2 MPRIP FBN1 ELAVL2 TLN2 MPHOSPH9	1.99e-03	1345	141	15	EFO_0010736
Disease	triglyceride measurement, intermediate density lipoprotein measurement	ABCA1 BPTF PNPLA3 TP53BP1	2.01e-03	111	141	4	EFO_0004530, EFO_0008595
Disease	triglycerides in HDL measurement	ABCA1 SIK3 TP53BP1	2.10e-03	53	141	3	EFO_0022317
Disease	Hypermetropia, Myopia	NCOA2 RNLS BPTF FRMPD2B PLCH1	2.19e-03	189	141	5	HP_0000540, HP_0000545
Disease	waist-hip ratio	C2orf69 ABCA1 ANK3 NSD1 SRGAP2 ZNF318 SIK3 RFX7 TSPAN9 MPRIP PPP1R3A BPTF UQCC1 MAML3	2.27e-03	1226	141	14	EFO_0004343
Disease	lung carcinoma	NUMBL UBASH3A ADAR BPTF FASN PCDH15 NCOA1 TP53BP1	2.29e-03	482	141	8	EFO_0001071
Disease	triglycerides in very large HDL measurement	ABCA1 SIK3 TP53BP1	2.34e-03	55	141	3	EFO_0022324
Disease	refractive error, age at onset, Myopia	RNLS BACH1 FBN1 ARID2 FRMPD2B	2.40e-03	193	141	5	EFO_0004847, HP_0000545, MONDO_0004892
Disease	neutrophil count	PRRX1 KIF1B MAML1 NSD1 ARHGEF12 WDR27 SIK3 ADAR TSPAN9 DPEP2 NCOA1 TLN2 PNPLA3 S1PR4 ZNF292	2.58e-03	1382	141	15	EFO_0004833
Disease	idiopathic pulmonary fibrosis	SRD5A2 MUC5B ZNF318	2.59e-03	57	141	3	EFO_0000768
Disease	free cholesterol to total lipids in medium VLDL percentage	ANKRD31 SIK3 TP53BP1	2.59e-03	57	141	3	EFO_0022284
Disease	level of triacylglycerol (56:6) in blood serum	SIK3 PNPLA3	2.60e-03	16	141	2	OBA_2020007
Disease	liver fat measurement, liver disease biomarker	PNPLA3 PCK2	2.60e-03	16	141	2	EFO_0006845, EFO_0010821
Disease	very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio	ANKRD31 ABCA1 SIK3 BPTF PNPLA3 TP53BP1	2.82e-03	291	141	6	EFO_0008317, EFO_0020946
Disease	Prostatic Neoplasms	NCOA2 NCOA3 PRRX1 SRD5A2 ARID2 NCOA1 FGF10 ABCG5 ZNF292	2.91e-03	616	141	9	C0033578
Disease	Malignant neoplasm of prostate	NCOA2 NCOA3 PRRX1 SRD5A2 ARID2 NCOA1 FGF10 ABCG5 ZNF292	2.91e-03	616	141	9	C0376358
Disease	1-Methylhistidine measurement	NCOA2 OTOGL	2.94e-03	17	141	2	EFO_0021543
Disease	Moyamoya Disease	ATP7A BRCC3	2.94e-03	17	141	2	C0026654
Disease	autosomal dominant intellectual developmental disorder (is_implicated_in)	RFX7 ZNF292	2.94e-03	17	141	2	DOID:0060307 (is_implicated_in)
Disease	cholesterol to total lipids in IDL percentage	SIK3 PNPLA3 TP53BP1	3.00e-03	60	141	3	EFO_0022233
Disease	PROSTATE CANCER, HEREDITARY, 1	RNLS RFX7 EMSY	3.00e-03	60	141	3	C4722327
Disease	triglycerides in small VLDL measurement	SIK3 BPTF TP53BP1	3.14e-03	61	141	3	EFO_0022145
Disease	free cholesterol in very large VLDL measurement	ANKRD31 SIK3 TP53BP1	3.14e-03	61	141	3	EFO_0022274
Disease	lobe attachment	KIF21B PRRX1 SIK3 UQCC1 SPIDR	3.24e-03	207	141	5	EFO_0007667
Disease	triglycerides in small HDL measurement	SIK3 BPTF TP53BP1	3.29e-03	62	141	3	EFO_0022158
Disease	phospholipids in large VLDL measurement	SIK3 BPTF TP53BP1	3.29e-03	62	141	3	EFO_0022169
Disease	triglycerides to total lipids in very large HDL percentage	SIK3 BPTF TP53BP1	3.29e-03	62	141	3	EFO_0022339
Disease	Hypercholesterolemia, Familial	ABCA1 ABCG5	3.30e-03	18	141	2	C0020445
Disease	familial hyperlipidemia (biomarker_via_orthology)	ABCA1 IRF9	3.68e-03	19	141	2	DOID:1168 (biomarker_via_orthology)
Disease	prostate carcinoma	RNLS NSD1 RFX7 EMSY DPEP2 PCDH15 ELAVL2 UQCC1 FGF10 MYOCD MAML3	3.76e-03	891	141	11	EFO_0001663
Disease	allergic rhinitis	ABCA1 SIK3 EMSY NEGR1	3.87e-03	133	141	4	EFO_0005854
Disease	breast carcinoma (is_marker_for)	NCOA3 SRD5A2 NCOA1	3.92e-03	66	141	3	DOID:3459 (is_marker_for)
Disease	prostate adenocarcinoma (is_implicated_in)	NCOA2 AKT3	4.07e-03	20	141	2	DOID:2526 (is_implicated_in)
Disease	total lipids in small VLDL	ANKRD31 SIK3 TP53BP1	4.09e-03	67	141	3	EFO_0022148
Disease	Microcephaly	TRRAP ORC1 ZNF292	4.09e-03	67	141	3	C0025958
Disease	triglycerides in very small VLDL measurement	SIK3 BPTF TP53BP1	4.27e-03	68	141	3	EFO_0022144
Disease	free cholesterol in large VLDL measurement	ANKRD31 SIK3 TP53BP1	4.27e-03	68	141	3	EFO_0022265
Disease	triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement	ANKRD31 ABCA1 PNPLA3 ABCG5 TP53BP1	4.61e-03	225	141	5	EFO_0008317, EFO_0020947

Protein segments in the cluster

Peptide	Gene	Start	Entry
SCTNTSNPSVMLGAG	ACO1	436	P21399
MSTATSEQAGPAEQC	BACH1	701	O14867
SLTAQSAMCTSQPQN	CATSPERD	616	Q86XM0
IGNASSCSQARTMNP	C2orf69	21	Q8N8R5
SPNLNANAVCDTMAV	ABCA12	1581	Q86UK0
AMTQHLTSPQVCEQS	ARMC6	376	Q6NXE6
ETSQLSQGLVCPMSV	MASTL	241	Q96GX5
SEMSTIRQNLGVCPQ	ABCA1	966	O95477
MENPSCRRGATNTSN	ARID2	1266	Q68CP9
TPAGCVESGENVMNT	CHAF1B	251	Q13112
ESTCIMNPEVVQSNG	ADAM32	341	Q8TC27
RLAAMEDTSTQGCQP	DNHD1	2011	Q96M86
ASCPESNSVNQVEDM	BPTF	1646	Q12830
SRMISPGLCQQNSQE	C2orf73	216	Q8N5S3
CSDMAVTFNGLTPNQ	C1GALT1C1	271	Q96EU7
TLQETMPCTGQNAAT	CECR2	1106	Q9BXF3
SQAECMGGSQAITSP	ATXN7L2	521	Q5T6C5
RMNCSPTSQIDNIGE	AKT3	116	Q9Y243
TTTEEGNQPGNMLNC	ALPK1	906	Q96QP1
QSPSSCADSQSQIME	ARHGEF12	1491	Q9NZN5
TQETVINIDGMTCNS	ATP7A	376	Q04656
TPSQMVANAFCSAAQ	NUMBL	511	Q9Y6R0
CNSRNQSPQLEGMAE	MUC5B	5376	Q9HC84
VQTAQPQASSSRMQC	RBM33	661	Q96EV2
QSNFSEPLNGCTMQL	NSD1	36	Q96L73
INSSCPPAENNMSVL	TIPARP	96	Q7Z3E1
SNGNPEQNSLACMRT	ANKRD31	1001	Q8N7Z5
SSGSSPQYNICEQMI	CYFIP1	336	Q7L576
CMITGTVGSISQSNL	MAML1	226	Q92585
MEGQNQDSTVPLCGA	MAP3K10	936	Q02779
TTLPQGTINMNQCTD	MPRIP	91	Q6WCQ1
MNNNTTCIQPSMISS	GPR82	1	Q96P67
AQRSMPLQTGTAQIC	HIPK2	631	Q9H2X6
NDMTVNEGTNVTLTC	NEGR1	146	Q7Z3B1
SQNPGTMATAAAQSE	MAML3	841	Q96JK9
MSQAELSTCSAPQTQ	NRARP	1	Q7Z6K4
CIIQMQGNSTSIINP	KIF1B	26	O60333
IPNITVNNSGSYMCQ	CEACAM6	286	P40199
QAQSEGISLQDMSCS	KRT38	296	O76015
IGTSTTCPANQMVNN	DUSP10	106	Q9Y6W6
GTSATTNPNAMATIQ	PCK2	356	Q16822
KSCVAVTSAQPQNMS	PLXNB2	516	O15031
RSQMPVSSQQASPCT	PNPLA3	406	Q9NST1
GGNSQTIMIACVSPS	KIF21B	336	O75037
SPSVCMNVSGNTQSV	IL27RA	461	Q6UWB1
QQEMSTSQPDCNVDS	MPHOSPH9	26	Q99550
CVVSMQGNTTSIINP	KIF1C	26	O43896
LSNVQPSDTMVTQCE	L1CAM	391	P32004
AVCAQSVNDPSNMSL	GABRB2	21	P47870
QLSEMANGCPHQTST	KCNK13	366	Q9HB14
NMKSISCQEIPGQQS	CFP	331	P27918
LTQIQEIMPNGTCNT	MROH8	196	Q9H579
MTDVPATFTQAECNG	ERMN	1	Q8TAM6
CVSPQEAAAMIPTQN	GREB1L	646	Q9C091
SPISSQVCTAQMAGL	MYOCD	676	Q8IZQ8
MSVNSTQEPLGCNYS	FAM131B	151	Q86XD5
VCALGNPATQATNMS	NUP155	636	O75694
NPATQATNMSCVTGP	NUP155	641	O75694
TTQESVPDVVQNMQC	PTPRQ	1376	Q9UMZ3
QDVTTMQTCNTKFPG	PARP12	466	Q9H0J9
PTFCQSGMENDTNNL	F2RL2	16	O00254
MASQPISTKSENICN	PPP1R3A	941	Q16821
GTTAMLSCEVAQPQT	OBSCN	1181	Q5VST9
NLGNPQMSQQTSCAS	ORC1	241	Q13415
QMSQQTSCASLDSPG	ORC1	246	Q13415
SPQCPVVVDTMQNQS	DIO1	191	P49895
NVSELQTMCPSEVTN	PCDH15	1911	Q96QU1
INPIQNGQCADSTMV	ATRX	1781	P46100
GQCNNAIPVDTVLTM	FBH1	966	Q8NFZ0
TCNIPTSNASNNMVT	ADAR	391	P55265
NMCQIGSSNRNPVTK	FBN1	2346	P35555
ENQETPSQQVGSMCS	CPHXL2	156	A0A1W2PPK0
PSQQVGSMCSSLEKQ	CPHXL2	161	A0A1W2PPK0
VPRSTQQCPSANDSM	FRMPD2B	46	Q6IN97
AESSVIPCESSNIQM	BORA	481	Q6PGQ7
SGSQRDVNCSVMGPQ	CTSC	46	P53634
NVSVTTNPMCAFTQG	ABCG5	591	Q9H222
SCQGLENETITMISN	ANK3	3751	Q12955
QKTTNESMENSCPQV	CEP162	416	Q5TB80
TPMVSCGNEQFLDNS	CCP110	566	O43303
METQLSNGPTCNNTA	ELAVL2	1	Q12926
EDAMQNCTLSPSVLQ	IRF9	146	Q00978
MGVIQCNPSANVSTV	DPEP2	316	Q9H4A9
MTSACTNIPGTVLTQ	KLF18	66	A0A0U1RQI7
TSIDNQTLCGEQMTT	KLF18	226	A0A0U1RQI7
TGNQTLCGEQMTTST	KLF18	256	A0A0U1RQI7
LCGEQMTTSTGNQAL	KLF18	261	A0A0U1RQI7
GEQMTTSTSNQTLCG	KLF18	291	A0A0U1RQI7
EQVMTSTSNQTLCGE	KLF18	446	A0A0U1RQI7
TSNQTLCGEQMTTPT	KLF18	536	A0A0U1RQI7
LCGEQMTTPTSNQTL	KLF18	541	A0A0U1RQI7
MTTPTSNQTLCGEQV	KLF18	546	A0A0U1RQI7
QTLCEEQVMTSTGNQ	KLF18	651	A0A0U1RQI7
STGNQALCGEQMTTS	KLF18	661	A0A0U1RQI7
ALCGEQMTTSTGNQA	KLF18	666	A0A0U1RQI7
LCGEQMTTSTGNQAL	KLF18	751	A0A0U1RQI7
NQTLCGEQMTTPTSN	KLF18	776	A0A0U1RQI7
GEQMTTPTSNQTLCG	KLF18	781	A0A0U1RQI7
TQQMGFVAQSCQPAS	KRTAP27-1	121	Q3LI81
SSVPVTCQALGQDMV	FGF10	31	O15520
TCQALGQDMVSPEAT	FGF10	36	O15520
GMANSTPQQQKCRES	EMSY	1196	Q7Z589
TGQQSQSGSPCIMDD	FAM135B	951	Q49AJ0
CLELPSQMGSVLNNS	CENPI	356	Q92674
EMCSQLQAQQSPAPT	FASN	2316	P49327
TPEQMATNVNCSSPE	FGF7	36	P21781
TGQMVAPSLNCSQKT	HPS1	551	Q92902
MNATGTPVAPESCQQ	S1PR4	1	O95977
TAGNFMECQPESSIS	EHMT1	596	Q9H9B1
VSQNCVTSPMNIDRN	EHMT1	1041	Q9H9B1
CVQVSITNATGPMDN	NEURL4	876	Q96JN8
EMNTGVDSSCQTIIP	CREB3L2	161	Q70SY1
CIIQMSGSTTTIVNP	KIF1A	26	Q12756
CVFQEVSVLNPGQSM	OTOGL	2116	Q3ZCN5
NPMISSVLLEGCNST	FAM114A1	521	Q8IWE2
CQTAVVSAQPEGMAS	NUTM2A	111	Q8IVF1
CQTAVVSAQPEGMAS	NUTM2B	111	A6NNL0
CQTAVVSAQPEGMAS	NUTM2E	111	B1AL46
CMTQPTASGTLRVQQ	RTKN	306	Q9BST9
VLSPQSCGNMSVQAL	RHNO1	131	Q9BSD3
MQQTPCVHSRTQAVG	RAPGEF4	246	Q8WZA2
LCMSVTTQAGNSSEQ	SFTPB	301	P07988
NSSEQAIPQAMLQAC	SFTPB	311	P07988
SSPVGMTSSACNNNN	NCOA1	516	Q15788
DQNPVESSMCQSNSR	NCOA3	576	Q9Y6Q9
MNQSTLAKECPLSQS	SATB2	186	Q9UPW6
NITTGASAASQTQMP	SIPA1L2	356	Q9P2F8
VALTCLGMQQPAQSQ	SIK3	791	Q9Y2K2
DMASQLCAQQPVQSE	SRGAP2C	351	P0DJJ0
NQAAMELGATVCTPQ	MUTYH	276	Q9UIF7
QGRCIPDMTQQGSSE	STARD9	1441	Q9P2P6
QSTPTGNMQASQELC	SPATA31C1	911	P0DKV0
SGTEPTCAAMNVNVG	SRPX	311	P78539
QEIVNIANCSTNMPG	NPTX2	386	P47972
NQMTAGNLAVCLAPS	STARD8	711	Q92502
TTDCMIQDQGNASPR	SEC24D	296	O94855
QGMLNSPTICQTFVG	ERVK-9	1086	P63128
NLCSQMSAVSGPLLQ	BRCC3	271	P46736
MELSQALPSSQVQCS	ANHX	341	E9PGG2
CSQTTSNVASQSMPP	ANKHD1	1026	Q8IWZ3
QPMANLCTPSSTANS	ANKHD1	2036	Q8IWZ3
EQNVCVMNPDLTGQT	NCOA2	376	Q15596
QALCSGNPGQDMTLS	NCOA2	406	Q15596
QLAESVSMCLQTGPT	STIL	891	Q15468
ANQSQTPCVQVLAGM	ERVFRD-1	246	P60508
SQVTNAAANCPGQMT	RNLS	291	Q5VYX0
MCEQLLGSPATSSSQ	SPIDR	316	Q14159
STLCQDISQAMNPID	SPATA31D1	276	Q6ZQQ2
SAQQLPACSVMFSGQ	RNF44	131	Q7L0R7
DMASQLCAQQPVQSE	SRGAP2	351	O75044
CVSDASQVNATVMPN	ZNF292	1516	O60281
MQVQCQQSPVLAGSA	SRD5A2	1	P31213
ISALTSCQMLPQGEN	TRABD2A	96	Q86V40
MAGQSCVQLSISQPA	USF3	721	Q68DE3
NCLGMTLQSQSVTPG	RFX7	811	Q2KHR2
TNAFSPMCTSRQVGN	SEMA5B	201	Q9P283
RPSQNNIGIQTMECS	TP53BP1	1146	Q12888
QMSQSRACGGSEQIP	UQCC1	46	Q9NVA1
DAKMFQTCVPQQSSA	PLCH1	1451	Q4KWH8
LNSVDSDNCGSMVPS	MTFR2	61	Q6P444
GEESLQSCMQFQPNS	NANOGP1	171	Q8N7R0
PTVSDQAAAMQLSQC	TLN2	1011	Q9Y4G6
QGMLNSPTICQTFVG	ERVK-19	166	Q9WJR5
QQCPSMGQSLSVPAS	WDR27	396	A2RRH5
VLVTLGSMVNTCQNP	UGT3A2	296	Q3SY77
SATCANNSPAQGINM	PRRX1	206	P54821
SMTLLQSQGNGSCSV	TCTN3	401	Q6NUS6
MPCHNQQVNSASTPS	UPRT	11	Q96BW1
TESMTGSPLQNQTAC	UHRF1BP1	856	Q6BDS2
TSCQGAMLPSITNVI	TRRAP	2511	Q9Y4A5
AMCLTGSPQEQGVSV	ZNF318	1901	Q5VUA4
VSSQRTSSVNQMCPE	ZSCAN5C	161	A6NGD5
TSSVNQMCPEEGQAS	ZSCAN5C	166	A6NGD5
VQVNGTPVMLQTTCA	TYSND1	461	Q2T9J0
MENSQGCGRNATTPL	TSPAN9	171	O75954
TNMSTQNRGNTSECI	ZNF560	231	Q96MR9
TASMVQIVNTCPQDT	UBASH3A	566	P57075
TGLQCEMDPVSQTQA	MYSM1	626	Q5VVJ2